MedTrace Logo

Impact of Melatonin on IVF/ICSI Outcomes in Prospective Poor Responders

NCT02993588 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2016-12-15

No results posted yet for this study

Summary

The purpose of this study is to investigate the impact of melatonin administration on in vitro fertilization (IVF/ICSI) outcomes namely the total number and quality of the oocytes and embryos in the prospective poor responders.

Conditions

  • In Vitro Fertilization
  • Poor Ovarian Response

Interventions

DRUG

Melatonin

Melatonin 6 mg tablet once daily

OTHER

Placebo

one tablet once daily

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Osama Abdalmageed, MD · Women health center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2017-08-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02993588 on ClinicalTrials.gov